Cargando…
Rituximab for the treatment of refractory anti-glomerular basement membrane disease
BACKGROUND: Anti-glomerular basement membrane (anti-GBM) disease is a rare but severe autoantibody-mediated immune disorder. The typical clinical presentation includes rapidly progressive glomerulonephritis and often concurrent pulmonary hemorrhage. The present study is aimed to investigate the ther...
Autores principales: | Yang, Xue-Fen, Jia, Xiao-Yu, Yu, Xiao-Juan, Cui, Zhao, Zhao, Ming-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291707/ https://www.ncbi.nlm.nih.gov/pubmed/35820833 http://dx.doi.org/10.1080/0886022X.2022.2097405 |
Ejemplares similares
-
The Prevalence and Characteristics of Circulating IgA Anti-Glomerular Basement Membrane Autoantibodies in Anti-Glomerular Basement Membrane Disease
por: Yang, Xue-fen, et al.
Publicado: (2023) -
Rituximab for the treatment of refractory simultaneous anti-glomerular basement membrane (anti-GBM) and membranous nephropathy
por: Bandak, Ghassan, et al.
Publicado: (2014) -
Rituximab for Anti–Glomerular Basement Membrane Disease
por: Jain, Rashmi, et al.
Publicado: (2018) -
Clinicopathological characteristics and outcome predictors of anti-glomerular basement membrane glomerulonephritis
por: Ge, Yifei, et al.
Publicado: (2022) -
Glomerular C1q deposition and serum anti-C1q antibodies in anti-glomerular basement membrane disease
por: Hu, Shui-yi, et al.
Publicado: (2013)